Discover how genetics influence irinotecan chemotherapy response through UGT1A1 polymorphisms and personalized cancer treatment approaches.
Clinical experience with pemetrexed in breast cancer treatment, exploring its mechanism, clinical trials, and therapeutic applications.
Exploring the potential of diiron vinyliminium complexes as next-generation anticancer agents with novel mechanisms of action.
Explore how GSTP1 genetic polymorphism affects toxicity in platinum-based chemotherapy and the future of personalized cancer treatment.
Discover how inhibiting the PI3K/Akt pathway can resensitize gastric cancer to chemotherapy drugs like vincristine, offering new hope for cancer treatment.
How a refined hepatic artery infusion (HAI) model is revolutionizing liver cancer treatment through direct drug delivery
Discover how cancer cells use ABCB1 pumps to expel both chemotherapy drugs and their metabolites, creating powerful treatment resistance.
Discover how lncRNA XIST helps lung cancer cells resist chemotherapy by turning them into sugar-guzzling factories through cellular glycolysis.
Exploring the groundbreaking three-drug combination of pemetrexed, gemcitabine, and cisplatin in cancer therapy through phase I clinical trials.